Related Experiment Video
Updated: May 11, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
Delirium associated with donepezil in a patient with Alzheimer's disease: a case report
Kamyar Mollazadeh-Moghaddam1, Arsia Jamali, Fatemeh Adili-Aghdam
1Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran ; National Drug and Poison Information Center, Deputy of Food and Drug, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Milad Clinical Research Center, Milad Hospital, Tehran, Iran.
Abstract:
Donepezil, a member of the acetylcholinesterase inhibitor family, is approved for management of cognitive impairments as well as behavioral complications in patients with neurodegenerative Alzheimer's disease. Generally, donepezil is regarded as a safe medication in patients with Alzheimer's disease although there have been reports of several minor adverse events including gastrointestinal disturbances. Herein we describe a patient with Alzheimer's disease who demonstrated delirious behavior upon treatment with donepezil.
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology